{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:01:51Z","timestamp":1790935311660,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,4,9]],"date-time":"2006-04-09T00:00:00Z","timestamp":1144540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1038\/nm1395","type":"journal-article","created":{"date-parts":[[2006,4,9]],"date-time":"2006-04-09T14:01:41Z","timestamp":1144591301000},"page":"580-584","source":"Crossref","is-referenced-by-count":137,"title":["Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor"],"prefix":"10.1038","volume":"12","author":[{"given":"Toya Nath","family":"Baral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Magez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Stijlemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Conrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Vanhollebeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Pays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Muyldermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"De Baetselier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,4,9]]},"reference":[{"key":"BFnm1395_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nature01461","volume":"422","author":"L Vanhamme","year":"2003","unstructured":"Vanhamme, L. et al. Apolipoprotein L\u2013I is the trypanosome lytic factor of human serum. Nature 422, 83\u201387 (2003).","journal-title":"Nature"},{"key":"BFnm1395_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0092-8674(00)81706-7","volume":"95","author":"HV Xong","year":"1998","unstructured":"Xong, H.V. et al. A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 95, 839\u2013846 (1998).","journal-title":"Cell"},{"key":"BFnm1395_CR3","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1074\/jbc.M307341200","volume":"279","author":"B Stijlemans","year":"2004","unstructured":"Stijlemans, B. et al. Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J. Biol. Chem. 279, 1256\u20131261 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm1395_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1473-3099(03)00488-2","volume":"3","author":"OC Hutchinson","year":"2003","unstructured":"Hutchinson, O.C., Fevre, E.M., Carrington, M. & Welburn, S.C. Lessons learned from the emergence of a new Trypanosoma brucei rhodesiense sleeping sickness focus in Uganda. Lancet Infect. Dis. 3, 42\u201345 (2003).","journal-title":"Lancet Infect. Dis."},{"key":"BFnm1395_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/S0140-6736(03)14694-6","volume":"362","author":"MP Barrett","year":"2003","unstructured":"Barrett, M.P. et al. The trypanosomiases. Lancet 362, 1469\u20131480 (2003).","journal-title":"Lancet"},{"key":"BFnm1395_CR6","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/S0140-6736(01)07096-9","volume":"358","author":"SC Welburn","year":"2001","unstructured":"Welburn, S.C. et al. Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene. Lancet 358, 2017\u20132019 (2001).","journal-title":"Lancet"},{"key":"BFnm1395_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1471-4922(00)01839-0","volume":"17","author":"SC Welburn","year":"2001","unstructured":"Welburn, S.C., Fevre, E.M., Coleman, P.G., Odiit, M. & Maudlin, I. Sleeping sickness: a tale of two diseases. Trends Parasitol. 17, 19\u201324 (2001).","journal-title":"Trends Parasitol."},{"key":"BFnm1395_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.mib.2004.05.001","volume":"7","author":"E Pays","year":"2004","unstructured":"Pays, E., Vanhamme, L. & Perez-Morga, D. Antigenic variation in Trypanosoma brucei: facts, challenges and mysteries. Curr. Opin. Microbiol. 7, 369\u2013374 (2004).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFnm1395_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2174\/1566524043360078","volume":"4","author":"D Horn","year":"2004","unstructured":"Horn, D. The molecular control of antigenic variation in Trypanosoma brucei. Curr. Mol. Med. 4, 563\u2013576 (2004).","journal-title":"Curr. Mol. Med."},{"key":"BFnm1395_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1473-3099(02)00321-3","volume":"2","author":"D Legros","year":"2002","unstructured":"Legros, D. et al. Treatment of human African trypanosomiasis \u2014 present situation and needs for research and development. Lancet Infect. Dis. 2, 437\u2013440 (2002).","journal-title":"Lancet Infect. Dis."},{"key":"BFnm1395_CR11","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0140-6736(00)02141-3","volume":"355","author":"C Burri","year":"2000","unstructured":"Burri, C. et al. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. Lancet 355, 1419\u20131425 (2000).","journal-title":"Lancet"},{"key":"BFnm1395_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-308X(08)60410-8","volume":"33","author":"J Pepin","year":"1994","unstructured":"Pepin, J. & Milord, F. The treatment of human African trypanosomiasis. Adv. Parasitol. 33, 1\u201347 (1994).","journal-title":"Adv. Parasitol."},{"key":"BFnm1395_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0169-4758(93)90145-6","volume":"9","author":"CJ Bacchi","year":"1993","unstructured":"Bacchi, C.J. Resistance to clinical drugs in African trypanosomes. Parasitol. Today 9, 190\u2013193 (1993).","journal-title":"Parasitol. Today"},{"key":"BFnm1395_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.ijpara.2004.04.008","volume":"34","author":"L Vanhamme","year":"2004","unstructured":"Vanhamme, L. & Pays, E. The trypanosome lytic factor of human serum and the molecular basis of sleeping sickness. Int. J. Parasitol. 34, 887\u2013898 (2004).","journal-title":"Int. J. Parasitol."},{"key":"BFnm1395_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0166-6851(94)90172-4","volume":"68","author":"C De Greef","year":"1994","unstructured":"De Greef, C. & Hamers, R. The serum resistance-associated (SRA) gene of Trypanosoma brucei rhodesiense encodes a variant surface glycoprotein-like protein. Mol. Biochem. Parasitol. 68, 277\u2013284 (1994).","journal-title":"Mol. Biochem. Parasitol."},{"key":"BFnm1395_CR16","first-page":"55","volume":"56","author":"N Van Meirvenne","year":"1976","unstructured":"Van Meirvenne, N., Maginus, E. & Janssens, P.G. The effect of normal human serum on trypanosomes of distinct antigenic type (ETat 1 to 12) isolated from a strain of Trypanosoma brucei rhodesiense. Ann. Soc. Belg. Med. Trop. 56, 55\u201363 (1976).","journal-title":"Ann. Soc. Belg. Med. Trop."},{"key":"BFnm1395_CR17","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0022-2275(20)33430-1","volume":"41","author":"PN Duchateau","year":"2000","unstructured":"Duchateau, P.N. et al. Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. J. Lipid Res. 41, 1231\u20131236 (2000).","journal-title":"J. Lipid Res."},{"key":"BFnm1395_CR18","doi-asserted-by":"publisher","first-page":"25576","DOI":"10.1074\/jbc.272.41.25576","volume":"272","author":"PN Duchateau","year":"1997","unstructured":"Duchateau, P.N. et al. Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L. J. Biol. Chem. 272, 25576\u201325582 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnm1395_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0065-2776(01)79006-2","volume":"79","author":"VK Nguyen","year":"2001","unstructured":"Nguyen, V.K., Desmyter, A. & Muyldermans, S. Functional heavy-chain antibodies in Camelidae. Adv. Immunol. 79, 261\u2013296 (2001).","journal-title":"Adv. Immunol."},{"key":"BFnm1395_CR20","first-page":"277","volume":"74","author":"S Muyldermans","year":"2001","unstructured":"Muyldermans, S. Single domain camel antibodies: current status. J. Biotechnol. 74, 277\u2013302 (2001).","journal-title":"J. Biotechnol."},{"key":"BFnm1395_CR21","doi-asserted-by":"publisher","first-page":"7346","DOI":"10.1074\/jbc.M007734200","volume":"276","author":"K Els Conrath","year":"2001","unstructured":"Els Conrath, K., Lauwereys, M., Wyns, L. & Muyldermans, S. Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J. Biol. Chem. 276, 7346\u20137350 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnm1395_CR22","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/glycob\/cwf079","volume":"12","author":"A Mehlert","year":"2002","unstructured":"Mehlert, A., Bond, C.S. & Ferguson, M.A. The glycoforms of a Trypanosoma brucei variant surface glycoprotein and molecular modeling of a glycosylated surface coat. Glycobiology 12, 607\u2013612 (2002).","journal-title":"Glycobiology"},{"key":"BFnm1395_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1126\/science.1114566","volume":"309","author":"D Perez-Morga","year":"2005","unstructured":"Perez-Morga, D. et al. Apolipoprotein L\u2013I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309, 469\u2013472 (2005).","journal-title":"Science"},{"key":"BFnm1395_CR24","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1158\/0008-5472.CAN-03-3935","volume":"64","author":"V Cortez-Retamozo","year":"2004","unstructured":"Cortez-Retamozo, V. et al. Efficient cancer therapy with a nanobody-based conjugate. Cancer Res. 64, 2853\u20132857 (2004).","journal-title":"Cancer Res."},{"key":"BFnm1395_CR25","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1128\/IAI.67.6.3128-3132.1999","volume":"67","author":"S Magez","year":"1999","unstructured":"Magez, S., Radwanska, M., Beschin, A., Sekikawa, K. & De Baetselier, P. Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect. Immun. 67, 3128\u20133132 (1999).","journal-title":"Infect. Immun."},{"key":"BFnm1395_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/381151","volume":"189","author":"S Magez","year":"2004","unstructured":"Magez, S. et al. P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis. J. Infect. Dis. 189, 527\u2013539 (2004).","journal-title":"J. Infect. Dis."},{"key":"BFnm1395_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4314\/eamj.v81i10.9232","volume":"81","author":"JE Chisi","year":"2004","unstructured":"Chisi, J.E., Misiri, H., Zverev, Y., Nkhoma, A. & Sternberg, J.M. Anaemia in human African trypanosomiasis caused by Trypanosoma brucei rhodesiense. East Afr. Med. J. 81, 505\u2013508 (2004).","journal-title":"East Afr. Med. J."},{"key":"BFnm1395_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2249.2004.02717.x","volume":"139","author":"J Naessens","year":"2005","unstructured":"Naessens, J. et al. TNF-\u03b1 mediates the development of anaemia in a murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection. Clin. Exp. Immunol. 139, 405\u2013410 (2005).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnm1395_CR29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/ijc.10212","volume":"98","author":"V Cortez-Retamozo","year":"2002","unstructured":"Cortez-Retamozo, V. et al. Efficient tumor targeting by single-domain antibody fragments of camels. Int. J. Cancer 98, 456\u2013462 (2002).","journal-title":"Int. J. Cancer"},{"key":"BFnm1395_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jmb.2005.04.050","volume":"350","author":"K Conrath","year":"2005","unstructured":"Conrath, K. et al. Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH. J. Mol. Biol. 350, 112\u2013125 (2005).","journal-title":"J. Mol. Biol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1395","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:26:44Z","timestamp":1684434404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["BFnm1395"],"URL":"https:\/\/doi.org\/10.1038\/nm1395","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1032038.374903","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1032038.372797","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1032038.372013","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,9]]}}}